According to EFSA’s register of questions, the 13.5 health claim application was under consideration but a deadline was yet to be given. The dossier was forwarded by the Austrian authority.
Under the European Union’s 2006 nutrition and health claims regulation (NHCR), products providing a daily intake of 3 g of creatine could already claim to “increase physical performance in successive bursts of short-term, high intensity exercise”.
Yet this claim could only be used for foods targeting adults performing high-intensity exercise.
AlzChem, headquartered in Trostberg, has over 1,400 employees and annual revenue of over €295m across the fields of nutrition, renewable energies, fine chemicals, agriculture and metallurgy.
Article 13.5 claims relate to proprietary and emerging science.